Determinants of left ventricular hypertrophy and diastolic dysfunction in an hiv clinical cohort

Given the remarkable improvement in the life expectancy of persons living with HIV (PLWH) worldwide, non-AIDS chronic diseases like cardiovascular disease (CVD) have emerged as leading causes of morbidity and mortality in this population. CVD is now the fourth leading cause of death among PLWH behind AIDS related malignancies/opportunistic infections, non-AIDS related malignancies and liver disease (1). After adjusting for known CVD risk factors, PLWH are at higher risk for major CVD events such as myocardial infarction, stroke and sudden cardiac death compared to uninfected persons (2, 3).

Source: Journal of Cardiac Failure - July 2, 2018 Category: Cardiology Authors: Nwora Lance Okeke, Fawaz Alenezi, Gerald S. Bloomfield, Allison Dunning, Meredith E. Clement, Svati H. Shah, Susanna Naggie, Eric J. Velazquez Tags: Clinical Investigation Source Type: research